T cells recognize and kill cancer cells but quickly lose their effectiveness. This fast dysfunction may help explain why immunotherapy doesn’t lead to long-term remission for many patients.
- MD-Ph.D. Candidate in Molecular Pathology and Immunology, Vanderbilt University
Contact Michael for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Location: Nashville, Tennessee, U.S.
- Article Feed
- Joined
